These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29464897)

  • 1. Case report of neuroleptic malignant syndrome with prolonged mental changes and severe dyskinesia.
    Chung YJ; Lee SJ
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 29464897
    [No Abstract]   [Full Text] [Related]  

  • 2. Poorly controlled EPS: risk factors for NMS.
    Primeau F; Fontaine R; Chouinard G
    Can J Psychiatry; 1987 May; 32(4):328, 331. PubMed ID: 2886211
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment.
    Spivak B; Weizman A; Wolovick L; Hermesh H; Tyano S; Munitz H
    Acta Psychiatr Scand; 1990 Feb; 81(2):168-9. PubMed ID: 1970216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The (frequently) neuroleptic (potentially) malignant syndrome.
    Kellam AM
    Br J Psychiatry; 1990 Aug; 157():169-73. PubMed ID: 1977485
    [No Abstract]   [Full Text] [Related]  

  • 5. A Case Report: Atypical Neuroleptic Malignant Syndrome on Clozapine and Mood Stabilizers.
    Amador EC; Kassam A; Hopp C; Cunningham EA
    J Clin Psychopharmacol; 2019; 39(5):518-519. PubMed ID: 31425460
    [No Abstract]   [Full Text] [Related]  

  • 6. Late-onset neuroleptic malignant syndrome in a patient using olanzapine.
    Kunz M; Gomes FA; Tramontina JF; Kapczinski F
    J Clin Psychopharmacol; 2007 Jun; 27(3):303-4. PubMed ID: 17502780
    [No Abstract]   [Full Text] [Related]  

  • 7. Dysphagia in a Case of Atypical Neuroleptic Malignant Syndrome.
    Truong TD; Mason DP
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):349-351. PubMed ID: 33734166
    [No Abstract]   [Full Text] [Related]  

  • 8. [The malignant neuroleptic syndrome].
    Pietzcker A
    Nervenarzt; 1988 Dec; 59(12):691-700. PubMed ID: 2905769
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic dysphoria.
    Emerich DF; Sanberg PR
    Biol Psychiatry; 1991 Feb; 29(3):201-3. PubMed ID: 1673062
    [No Abstract]   [Full Text] [Related]  

  • 10. Clozapine treatment and neuroleptic malignant syndrome.
    Doan RJ; Callaghan WD
    Can J Psychiatry; 2000 May; 45(4):394-5. PubMed ID: 10813077
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report.
    Gönner F; Baumgartner R; Schüpbach D; Merlo MC
    Psychopharmacology (Berl); 1999 Jun; 144(4):416-8. PubMed ID: 10435416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia and current dose of neuroleptic drugs.
    Kolakowska T; Williams AO; Ardern M
    Arch Gen Psychiatry; 1985 Sep; 42(9):925. PubMed ID: 2864034
    [No Abstract]   [Full Text] [Related]  

  • 13. Antipsychotic induced movement disorders.
    Ramesh S; Sagar R
    Indian J Med Sci; 2001 Sep; 55(9):483-7. PubMed ID: 11887297
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].
    Barrimi M; El Ghazouani F; Zaimi O; Oneib B
    Presse Med; 2018 Feb; 47(2):172-174. PubMed ID: 29395559
    [No Abstract]   [Full Text] [Related]  

  • 15. Rechallenging clozapine after neuroleptic malignant syndrome.
    Anbalagan E; Ithman M; Lauriello J
    Psychiatr Q; 2014 Sep; 85(3):345-8. PubMed ID: 24633526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome.
    Trutia A; Bledowski J; Pandurangi A; Kahn DA
    J Psychiatr Pract; 2008 Nov; 14(6):398-402. PubMed ID: 19057242
    [No Abstract]   [Full Text] [Related]  

  • 17. Lurasidone-Associated Neuroleptic Malignant Syndrome.
    Lee M; Marshall D; Saddichha S
    J Clin Psychopharmacol; 2017 Oct; 37(5):639-640. PubMed ID: 28806387
    [No Abstract]   [Full Text] [Related]  

  • 18. Movement disorders and the treatment of schizophrenia.
    Ellard J
    Australas Psychiatry; 2004 Dec; 12(4):409. PubMed ID: 15715820
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome associated with quetiapine.
    al-Waneen R
    Can J Psychiatry; 2000 Oct; 45(8):764-5. PubMed ID: 11086565
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome superimposed on tardive dyskinesia.
    Haggerty JJ; Bentsen BS; Gillette GM
    Br J Psychiatry; 1987 Jan; 150():104-5. PubMed ID: 2888500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.